Stock Traders Purchase High Volume of Cytokinetics Call Options (NASDAQ:CYTK)

Stock Traders Purchase High Volume of Cytokinetics Call Options (NASDAQ:CYTK)

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) was the recipient of unusually large options trading activity on Monday. Investors purchased 21,076 call options on the company. This is an increase of 1,008% compared to the typical volume of 1,902 call options. Analysts Set New Price Targets CYTK has been the subject of several recent analyst reports. Raymond James Financial initiated coverage on Cytokinetics in a research note on Wedn…